Xenetic Biosciences (NASDAQ:XBIO) reported quarterly losses of $(0.41) per share. This is a 8.89 percent increase over losses of $(0.45) per share from the same period last year. The company reported $660.601 thousand in sales this quarter. This is a 11.99 percent increase over sales of $589.897 thousand the same period last year.